🌩️ Anesthetic Considerations in Preeclampsia

🔷 INTRODUCTION

Preeclampsia is a multisystem hypertensive disorder of pregnancy, defined as the new onset of hypertension and end-organ dysfunction (with or without proteinuria) after 20 weeks gestation. It can progress to eclampsia, HELLP syndrome, or other life-threatening complications if not managed promptly.

It presents major anesthetic concerns due to vascular instability, altered pharmacodynamics, risk of seizures, coagulopathy, airway edema, and poor end-organ perfusion.

🔷 DEFINITION

  • Hypertension in pregnancy: SBP ≥140 mmHg or DBP ≥90 mmHg on 2 occasions ≥4 hours apart after 20 weeks gestation.
  • Preeclampsia: Hypertension PLUS one of the following:
    • Proteinuria ≥300 mg/24 hrs or ≥1+ on dipstick,Protein to Creat Ratio_>0.3
    • Platelet count <100,000/mm³
    • Elevated liver enzymes (AST/ALT), right upper quadrant pain
    • Renal insufficiency (serum creatinine >1.1 mg/dL)
    • Pulmonary edema
    • Cerebral or visual disturbances

🔹 Severe Preeclampsia

  • SBP ≥160 mmHg or DBP ≥110 mmHg
  • Marked end-organ dysfunction

🔹 Eclampsia

  • Criteria of preeclampsia + new-onset seizures (generalized tonic-clonic)
  • No pre-existing seizure disorder


🔷 ETIOPATHOGENESIS 

  • Abnormal trophoblastic invasion spiral artery remodeling failure
  • High-resistance uteroplacental circulation placental hypoxia
  • Endothelial dysfunction release of vasoactive substances
  • Vasospasm, capillary leak, and microthrombi multisystem involvement


🔷 SYSTEMIC EFFECTS OF PREECLAMPSIA

System

Changes

CVS

SVR, BP, intravascular volume, afterload

Renal

GFR, U/O, uric acid/creatinine

Hematologic

Thrombocytopenia, DIC, hemolysis

Liver

AST/ALT, subcapsular hematoma, HELLP syndrome

CNS

Headache, visual changes, seizures (eclampsia), PRES

Respiratory

Pulmonary edema (capillary leak), compliance

Placenta/Fetus

Uteroplacental insufficiency, IUGR, fetal distress


🔷 INVESTIGATIONS

  • CBC: Platelets, Hb
  • Liver enzymes: AST, ALT
  • Renal function: Creatinine, Uric acid
  • Coagulation: PT, aPTT, INR
  • Urinalysis: Proteinuria (24-hour collection or dipstick)
  • Fundoscopy: Retinal vasospasm
  • Fetal monitoring: USG, CTG


🔷 DRUG THERAPY BEFORE DELIVERY

Drug

Purpose

Notes

Magnesium Sulfate

Seizure prophylaxis

4 g IV bolus + 1–2 g/hr infusion; monitor for toxicity

Labetalol

BP control

α and β blocker; IV bolus 20 mg titrate

Hydralazine

BP control

Arteriolar dilator; may cause reflex tachycardia

Nifedipine

Oral BP control

Calcium channel blocker

Corticosteroids

Fetal lung maturity

Betamethasone 12 mg IM q24h ×2

⚠️ Avoid NSAIDs (renal compromise), Ergot alkaloids (vasospasm)


🔷 ANESTHETIC GOALS

  • Avoid sudden rise/fall in BP
  • Prevent seizures
  • Maintain uteroplacental perfusion
  • Maintain airway patency (edema risk)
  • Volume control – avoid overload (risk of pulmonary edema)
  • Be ready for emergency delivery
  • Ensure adequate fetal monitoring
  • Be cautious with drug dosages due to altered pharmacokinetics


🔷 REGIONAL ANESTHESIA

Preferred if no contraindications

🔹 Spinal Anesthesia

  • Acceptable in stable, well-controlled preeclampsia
  • Use reduced dose of bupivacaine (due to decreased CSF volume)
  • Combine with opioids for enhanced analgesia

Contraindications: Platelet <75,000/mm³, coagulopathy, hemodynamic instability

🔹 Epidural Anesthesia

  • Preferred in laboring patients
  • Slower onset, better hemodynamic control
  • Can be titrated for cesarean delivery if needed

🔹 Combined Spinal-Epidural (CSE)

  • Useful in labor analgesia or cesarean
  • Offers rapid onset and titration


🔷 GENERAL ANESTHESIA

High-risk, used only when regional is contraindicated

🔹 Indications

  • Eclampsia (seizing or postictal)
  • Coagulopathy (low platelets)
  • Emergency cesarean delivery
  • Failed regional block

🔹 Considerations

  • Difficult airway: Anticipate edema and poor visibility
  • Rapid desaturation: Preoxygenate thoroughly
  • Pressor response to laryngoscopy: Use fentanyl, esmolol, lidocaine
  • Drug interaction with MgSO₄:
    • Potentiates NMBs (especially non-depolarizing)
    • Decreased ACh release prolonged paralysis
    • Use lower doses of muscle relaxants and monitor neuromuscular function
  • Cricoid pressure, aspiration prophylaxis mandatory


🔷 INTRAOPERATIVE MONITORING

  • Standard ASA monitors
  • Invasive BP monitoring (ART line) for severe cases
  • CVP if fluid management is challenging
  • Urine output hourly (foley catheter)
  • Neuromuscular monitoring if MgSO₄ is used
  • Fetal monitoring (CTG) if gestational age permits


🔷 FLUID MANAGEMENT

  • Preeclamptics are intravascularly dry but extracellularly overloaded
  • Restrictive fluid strategy: ~75–100 mL/hr of crystalloid unless hypovolemic
  • Avoid overhydration (pulmonary edema risk)
  • Colloids may be considered during volume shifts (e.g., hemorrhage)


🔷 POSTOPERATIVE CARE

  • Continue magnesium sulfate for 24 hours postpartum
  • Monitor for seizures, pulmonary edema, PPH
  • Continue BP control
  • Vigilant monitoring in high-dependency or ICU setting
  • Early ambulation, DVT prophylaxis
  • Pain control: Epidural infusion if catheter retained


🔷 COMPLICATIONS

 

Complication

Management

Seizure (Eclampsia)

MgSO, airway control, delivery

Pulmonary edema

Oxygen, diuretics, fluid restriction

HELLP syndrome

Blood products, early delivery

Renal failure

Monitor U/O, renal profile

Abruptio placentae

Resuscitate, expedite delivery


🔹 Magnesium Sulfate Toxicity

Sign

Plasma Level (mEq/L)

Loss of DTR

>5

Respiratory depression

>10

Cardiac arrest

>15

  • Antidote: 10 mL of 10% Calcium Gluconate IV over 10 mins



🔷 MCQ PEARLS

Question

Answer

Drug of choice for seizure prophylaxis

Magnesium sulfate

Magnesium toxicity antidote

Calcium gluconate

Preferred vasopressor in preeclampsia

Phenylephrine

Platelet cutoff for spinal

75,000/mm³

Most feared complication

Eclampsia


🔷 CONCLUSION

Preeclampsia is a multisystem disorder with profound anesthetic implications. Careful preoperative evaluation, choice of safe anesthesia technique (regional > GA), meticulous intraoperative management, and vigilant postoperative monitoring are critical for maternal and fetal safety. The anesthesiologist plays a central role in managing this high-risk obstetric condition.